🔎 Trials Near Me

Akèy › Glomeruloskleroz fokal segmantè › Minnesota › Minneapolis

Etid klinik pou Glomeruloskleroz fokal segmantè nan Minneapolis, MN

3 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan ak bò kote Minneapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

Ap rekrite
  • University of Minnesota, Minneapolis
Jiska laj 21 · Tout sèks · Mizajou Aug 28, 2026 · NCT02235857

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Ap rekriteFaz 2
  • University of Minnesota, Masonic Children's Hospital, Minneapolis
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Ap rekriteFaz 3
  • University of Minnesota, Minneapolis
Laj 12 a 80 · Tout sèks · Mizajou Feb 3, 2026 · NCT05183646

Etid Glomeruloskleroz fokal segmantè nan lòt vil

Lòt etid nan Minneapolis

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.